Cargando…
Coeliac disease detection with an IgA/IgG-deamidated gliadin peptide based point of care test in community pharmacies
Background Coeliac disease affects 1% of the population, but 75% remain undiagnosed. Objective To conduct a case finding feasibility and efficacy study for the detection of coeliac disease in community pharmacies. Setting Six community pharmacies across Sheffield, UK. Method A prospective study was...
Autores principales: | Lau, Michelle S., Sanders, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509084/ https://www.ncbi.nlm.nih.gov/pubmed/30778740 http://dx.doi.org/10.1007/s11096-019-00793-8 |
Ejemplares similares
-
Isolated positive deamidated gliadin peptide‐IgG has limited diagnostic utility in coeliac disease
por: Vootukuru, Nikil, et al.
Publicado: (2022) -
‘Pre-endoscopy point of care test (Simtomax- IgA/IgG-Deamidated Gliadin Peptide) for coeliac disease in iron deficiency anaemia: diagnostic accuracy and a cost saving economic model’
por: Lau, Michelle Shui Yee, et al.
Publicado: (2016) -
Erratum to: ‘Pre-endoscopy point of care test (Simtomax- IgA/IgG-Deamidated Gliadin Peptide) for coeliac disease in iron deficiency anaemia: diagnostic accuracy and a cost saving economic model’
por: Lau, Michelle Shui Yee, et al.
Publicado: (2016) -
Coeliac disease in infants: antibodies to deamidated gliadin peptide come first!
por: Arigliani, Michele, et al.
Publicado: (2017) -
Diagnostic Accuracy of IgA Anti-Transglutaminase and IgG Anti-Deamidated Gliadin for Diagnosis of Celiac Disease in Children under Two Years of Age: A Systematic Review and Meta-Analysis
por: Catassi, Giulia N., et al.
Publicado: (2021)